The pharmacology of sigma-1 receptors.
暂无分享,去创建一个
[1] J. Xu,et al. Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor. , 1997, European journal of pharmacology.
[2] T. Nabeshima,et al. Effects of σ 1 receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats , 2000, Neuropharmacology.
[3] S. Takahashi,et al. Involvement of σ1 receptors in methamphetamine-induced behavioral sensitization in rats , 2000, Neuroscience Letters.
[4] Sarah L Parylak,et al. Sigma-1 receptor knockout mice display a depressive-like phenotype , 2009, Behavioural Brain Research.
[5] C. Parenti,et al. A new sigma ligand, (+/-)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect. , 2008, Life sciences.
[6] G. Debonnel,et al. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors , 2007, Journal of psychopharmacology.
[7] G. Debonnel,et al. Modulation of the firing activity of female dorsal raphe nucleus serotonergic neurons by neuroactive steroids. , 2004, The Journal of endocrinology.
[8] Protein kinase C , 1998 .
[9] S. Goldberg,et al. Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls , 2004, Psychopharmacology.
[10] Yueh-Ching Chou,et al. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan , 1999, Brain Research.
[11] L. Montoliu,et al. Formalin-induced pain is reduced in σ1 receptor knockout mice , 2005 .
[12] T. Yorio,et al. sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation. , 2008, Investigative ophthalmology & visual science.
[13] P. Romieu,et al. Involvement of the sigma1 receptor in the motivational effects of ethanol in mice , 2003, Pharmacology Biochemistry and Behavior.
[14] T. Maurice. Beneficial effect of the sigma(1) receptor agonist PRE-084 against the spatial learning deficits in aged rats. , 2001, European journal of pharmacology.
[15] Shuxian Hu,et al. Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. , 2006, International immunopharmacology.
[16] P. Romieu,et al. Involvement of the Sigma1 Receptor in the Appetitive Effects of Cocaine , 2004, Pharmacopsychiatry.
[17] T. Nabeshima,et al. Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein. , 2004, European Journal of Pharmacology.
[18] T. Maurice. Neurosteroids and σ1 Receptors, Biochemical and Behavioral Relevance , 2004, Pharmacopsychiatry.
[19] M. Iyo,et al. No Association Found between the Type 1 Sigma Receptor Gene Polymorphisms and Methamphetamine Abuse in the Japanese Population: A Collaborative Study by the Japanese Genetics Initiative for Drug Abuse , 2004, Annals of the New York Academy of Sciences.
[20] Teruo Hayashi,et al. σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export , 2003, Journal of Pharmacology and Experimental Therapeutics.
[21] G. Skuza,et al. A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist. , 2002, Behavioural pharmacology.
[22] Megan Lerner,et al. σ Receptors: potential medications development target for anti-cocaine agents , 2003 .
[23] Gianluca Bontempi,et al. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. , 2007, Neoplasia.
[24] T. Nabeshima,et al. Enhanced antidepressant efficacy of σ1 receptor agonists in rats after chronic intracerebroventricular infusion of β-amyloid-(1–40) protein , 2004 .
[25] Koki Kato,et al. TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons , 1999, Neuroscience Letters.
[26] A. Beitz,et al. Intrathecal Injection of the &sfgr;1 Receptor Antagonist BD1047 Blocks Both Mechanical Allodynia and Increases in Spinal NR1 Expression during the Induction Phase of Rodent Neuropathic Pain , 2008, Anesthesiology.
[27] H. Ujike,et al. No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies , 2003, BMC psychiatry.
[28] R. Leadbetter,et al. A placebo-controlled trial of igmesine in the treatment of major depression , 1999, European Neuropsychopharmacology.
[29] G. Cantarella,et al. Protective effects of the sigma agonist Pre-084 in the rat retina , 2007, British Journal of Ophthalmology.
[30] R. Traystman,et al. sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. , 2000, Stroke.
[31] S. Takahashi,et al. Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats. , 2000, Neuroscience Letters.
[32] G. Debonnel,et al. Modulation of serotonergic neurotransmission by short‐ and long‐term treatments with sigma ligands , 2001, British journal of pharmacology.
[33] R. Andrew,et al. Spreading depression: imaging and blockade in the rat neocortical brain slice. , 2002, Journal of neurophysiology.
[34] D. Gruol,et al. Steroid pregnenolone sulfate enhances NMDA‐receptor‐independent long‐term potentiation at hippocampal CA1 synapses: Role for L‐type calcium channels and sigma‐receptors , 2007, Hippocampus.
[35] A. Sadikot,et al. Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies. , 2008, The international journal of neuropsychopharmacology.
[36] S. Homan,et al. Overexpression of σ Receptors in Nonneural Human Tumors , 1991 .
[37] D. W. Parish,et al. PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice , 1994, Pharmacology Biochemistry and Behavior.
[38] R. Matsumoto. Sigma Receptors: Chemistry, Cell Biology And Clinical Implications , 2007 .
[39] S. Kulkarni,et al. Possible involvement of sigma‐1 receptors in the anti‐immobility action of bupropion, a dopamine reuptake inhibitor , 2008, Fundamental & clinical pharmacology.
[40] A. Urani,et al. Enhanced antidepressant effect of sigma1 (σ1) receptor agonists in β25–35-amyloid peptide-treated mice , 2002, Behavioural Brain Research.
[41] M. Roth,et al. Cocaine modulates cytokine and enhances tumor growth through sigma receptors , 2004, Journal of Neuroimmunology.
[42] Yueh-Ching Chou,et al. Dimemorfan protects rats against ischemic stroke through activation of sigma‐1 receptor‐mediated mechanisms by decreasing glutamate accumulation , 2007, Journal of neurochemistry.
[43] P. Zheng,et al. Neurosteroid dehydroepiandrosterone sulphate inhibits persistent sodium currents in rat medial prefrontal cortex via activation of sigma-1 receptors , 2008, Experimental Neurology.
[44] Haloperidol induces apoptosis via the sigma2 receptor system and Bcl-XS. , 2006, The pharmacogenomics journal.
[45] Chieh-fu Chen,et al. Anti‐amnesic effect of dimemorfan in mice , 2003, British journal of pharmacology.
[46] A. Prescott,et al. Sigma receptor antagonists inhibit human lens cell growth and induce pigmentation. , 2005, Investigative ophthalmology & visual science.
[47] G. Baldwin,et al. Cocaine and σ‐1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL‐SCID model , 2005, Journal of leukocyte biology.
[48] W. Bowen,et al. Highly selective σ receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes , 1998 .
[49] G. Pasternak,et al. Modulation of Brainstem Opiate Analgesia in the Rat by σ1 Receptors: A Microinjection Study , 2007, Journal of Pharmacology and Experimental Therapeutics.
[50] P. Holmes. Olfactory bulbectomy increases prepro-enkephalin mRNA levels in the ventral striatum in rats , 1999, Neuropeptides.
[51] G. Hortobagyi,et al. Expression of sigma 1 receptor in human breast cancer , 2004, Breast Cancer Research and Treatment.
[52] E. Aydar,et al. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. , 2007, Cancer research.
[53] G. Pasternak,et al. Sigma1 receptor modulation of opioid analgesia in the mouse. , 2002, The Journal of pharmacology and experimental therapeutics.
[54] E. Ikonen,et al. How cells handle cholesterol. , 2000, Science.
[55] P. Casellas,et al. Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors , 2000, British Journal of Cancer.
[56] J. Cuevas,et al. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. , 2002, Journal of neurophysiology.
[57] J. Thompson,et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.
[58] V. Ganapathy,et al. Cloning and functional characterization of a sigma receptor from rat brain. , 1998, Journal of neurochemistry.
[59] M. Ohyama,et al. Low density of sigma1 receptors in early Alzheimer’s disease , 2008, Annals of nuclear medicine.
[60] J. Ieni,et al. The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor , 2006, British journal of pharmacology.
[61] Teruo Hayashi,et al. σ‐1 Receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: Potential relation to lipid raft reconstitution , 2004, Synapse.
[62] Mario Schelhaas,et al. Simian Virus 40 Depends on ER Protein Folding and Quality Control Factors for Entry into Host Cells , 2007, Cell.
[63] W. Bowen,et al. σ2 Receptors regulate changes in sphingolipid levels in breast tumor cells , 2002 .
[64] J. Nylandsted,et al. Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation , 2008, Autophagy.
[65] P. Romieu,et al. Involvement of the σ1 receptor in the cocaine‐induced conditioned place preference , 2000 .
[66] T. Kameyama,et al. Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice , 2000, Neuropharmacology.
[67] D. B. Vaupel,et al. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. , 1983, European journal of pharmacology.
[68] G. Skuza,et al. Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats. , 2003, Polish journal of pharmacology.
[69] X. Codony,et al. Sigma receptors: biology and therapeutic potential , 2004, Psychopharmacology.
[70] P. Sexton,et al. Involvement of the sigma1 (σ1) receptor in the anti‐amnesic, but not antidepressant‐like, effects of the aminotetrahydrofuran derivative ANAVEX1‐41 , 2007, British journal of pharmacology.
[71] T. Maurice,et al. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. , 2006, Journal of pharmacological sciences.
[72] R. Epand,et al. Protein Kinase C , 1993, British Journal of Cancer.
[73] C. Montigny,et al. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors , 1990 .
[74] L. Cazin,et al. A-Current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway. , 1999, The Journal of pharmacology and experimental therapeutics.
[75] W. Bowen,et al. Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation , 2008, Journal of Biological Chemistry.
[76] E. Aydar,et al. The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines. , 2006, Cancer letters.
[77] V. Dawson,et al. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. , 2001, Stroke.
[78] K. Jansen,et al. Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss , 1993, Brain Research.
[79] M. Barcikowska,et al. Sigma Receptor Type 1 Gene Variation in a Group of Polish Patients with Alzheimer’s Disease and Mild Cognitive Impairment , 2007, Dementia and Geriatric Cognitive Disorders.
[80] D. Mousseau,et al. Haloperidol induces apoptosis via the σ2 receptor system and Bcl-XS , 2006, The Pharmacogenomics Journal.
[81] W. Bowen,et al. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. , 2002, Cancer research.
[82] Meyer B. Jackson,et al. The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit , 2002, Neuron.
[83] T. Nabeshima,et al. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. , 2000, Pharmacology & therapeutics.
[84] A. Prescott,et al. Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth in Vitro and in Vivo , 2004, Cancer Research.
[85] G. Pasternak,et al. Molecular cloning and pharmacological characterization of the rat sigma1 receptor. , 2001, Biochemical pharmacology.
[86] M. Denavit-Saubié,et al. Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[87] D. B. Vaupel,et al. Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog , 1983 .
[88] K. Matsuno,et al. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. , 1993, The Journal of pharmacology and experimental therapeutics.
[89] M. Kuhar,et al. Cocaine binding at sigma receptors. , 1988, European journal of pharmacology.
[90] J. Cuevas,et al. σ Receptor Activation Blocks Potassium Channels and Depresses Neuroexcitability in Rat Intracardiac Neurons , 2005, Journal of Pharmacology and Experimental Therapeutics.
[91] G. Debonnel,et al. Effects of the Potential Antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone Monomethanesulfonate] a Combined σ and 5-HT1A Ligand: Modulation of Neuronal Activity in the Dorsal Raphe Nucleus , 2004, Journal of Pharmacology and Experimental Therapeutics.
[92] P. Casellas,et al. Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. , 2001, Brain research. Molecular brain research.
[93] D. W. Parish,et al. PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. , 1994, Pharmacology, biochemistry, and behavior.
[94] H. Suwaki,et al. Lack of association between sigma1 receptor gene variants and schizophrenia , 2004, Psychiatry and clinical neurosciences.
[95] X. Langlois,et al. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. , 2004, European journal of pharmacology.
[96] Tangui Maurice,et al. Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice , 2009, Neuropsychopharmacology.
[97] P. Romieu,et al. Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. , 2000, Neuroreport.
[98] H. Guizouarn,et al. Cancer Cell Cycle Modulated by a Functional Coupling between Sigma-1 Receptors and Cl– Channels* , 2007, Journal of Biological Chemistry.
[99] T. Hupp,et al. HIF-1α contributes to tumour-selective killing by the sigma receptor antagonist rimcazole , 2007, Oncogene.
[100] T. Su. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. , 1982, The Journal of pharmacology and experimental therapeutics.
[101] M. Sokabe,et al. DHEA-Neuroprotection and -Neurotoxicity after Transient Cerebral Ischemia in Rats , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[102] R. Wilke,et al. Sigma Receptor Photolabeling and Sigma Receptor-mediated Modulation of Potassium Channels in Tumor Cells* , 1999, The Journal of Biological Chemistry.
[103] K. Hashimoto,et al. Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[104] W. Bowen,et al. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells. , 2003, Cellular and molecular biology.
[105] G. Debonnel,et al. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. , 1990, European journal of pharmacology.
[106] T. Kameyama,et al. Beneficial Effects of Acute and Repeated Administrations of σ Receptor Agonists on Behavioral Despair in Mice Exposed to Tail Suspension , 1998, Pharmacology Biochemistry and Behavior.
[107] R. Koehler,et al. Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. , 2003, Anesthesia and analgesia.
[108] Yuko Fujita,et al. Phencyclidine-Induced Cognitive Deficits in Mice are Improved by Subsequent Subchronic Administration of Fluvoxamine: Role of Sigma-1 Receptors , 2007, Neuropsychopharmacology.
[109] P. Romieu,et al. Involvement of the Sigma1 Receptor in Cocaine-induced Conditioned Place Preference: Possible Dependence on Dopamine Uptake Blockade , 2002, Neuropsychopharmacology.
[110] A. Urani,et al. The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities , 2001, Brain Research Reviews.
[111] W. Bowen,et al. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. , 1995, Cancer research.
[112] W. Bowen,et al. sigma(2) Receptors regulate changes in sphingolipid levels in breast tumor cells. , 2002, European journal of pharmacology.
[113] E. Mazzon,et al. A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors. , 2006, European journal of pharmacology.
[114] W. Bowen,et al. Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides , 2002, Neuropharmacology.
[115] H. Volz,et al. Clinical trials with sigma ligands. , 2004, Pharmacopsychiatry.
[116] Teruo Hayashi,et al. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. , 2003, The Journal of pharmacology and experimental therapeutics.
[117] A. Privat,et al. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via σ1-receptors , 1997, Behavioural Brain Research.
[118] V. Ganapathy,et al. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. , 2008, Investigative ophthalmology & visual science.
[119] P. Romieu,et al. Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity , 2002, Neuroscience & Biobehavioral Reviews.
[120] W. Bowen,et al. ς1 Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward , 2003, The Journal of Neuroscience.
[121] D. Monaghan,et al. Interaction with σ1 Protein, but Not N-Methyl-d-aspartate Receptor, Is Involved in the Pharmacological Activity of Donepezil , 2006, Journal of Pharmacology and Experimental Therapeutics.
[122] L. Cazin,et al. The ς-ligand (+)-pentazocine depresses M current and enhances calcium conductances in frog melanotrophs. , 1999, American journal of physiology. Endocrinology and metabolism.
[123] J. Meunier,et al. Beneficial effects of the sigma1 receptor agonists igmesine and dehydroepiandrosterone against learning impairments in rats prenatally exposed to cocaine. , 2004, Neurotoxicology and teratology.
[124] Mitsutoshi Yamamoto,et al. A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[125] Teruo Hayashi,et al. Intracellular Dynamics of σ-1 Receptors (σ1 Binding Sites) in NG108-15 Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.
[126] A. Christopoulos,et al. Involvement of the sigma 1 ( r 1 ) receptor in the anti-amnesic , but not antidepressant-like , effects of the aminotetrahydrofuran derivative ANAVEX 1-41 , 2007 .
[127] W. Bowen,et al. Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling , 1994 .
[128] Guoyao Wu,et al. Beneficial effects of l-arginine on reducing obesity: potential mechanisms and important implications for human health , 2010, Amino Acids.
[129] A. Beitz,et al. Intrathecal treatment with σ1 receptor antagonists reduces formalin‐induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice , 2006, British journal of pharmacology.
[130] D. Gruol,et al. Emergence of NMDAR‐independent long‐term potentiation at hippocampal CA1 synapses following early adolescent exposure to chronic intermittent ethanol: Role for sigma‐receptors , 2008, Hippocampus.
[131] L. Combettes,et al. Protein Kinase C-Dependent Potentiation of Intracellular Calcium Influx by σ1 Receptor Agonists in Rat Hippocampal Neurons , 2003, Journal of Pharmacology and Experimental Therapeutics.
[132] N. M. Rao,et al. Haloperidol-associated Stealth Liposomes , 2005, Journal of Biological Chemistry.
[133] M. Sokabe,et al. Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor , 2006, Neuropharmacology.
[134] T. Su,et al. The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. , 2001, The Journal of pharmacology and experimental therapeutics.
[135] V. Ganapathy,et al. Cloning and Functional Characterization of a σ Receptor from Rat Brain , 1998 .
[136] A. Beitz,et al. Intrathecal administration of sigma‐1 receptor agonists facilitates nociception: Involvement of a protein kinase C–dependent pathway , 2008, Journal of neuroscience research.
[137] M. Sokabe,et al. Chronic administration of dehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of long-term potentiation via sigma 1 (σ1) receptor: Optical imaging study in rat hippocampal slices , 2006, Neuropharmacology.
[138] M. Kuhar,et al. Cocaine binding at σ receptors , 1988 .
[139] Y. Minabe,et al. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. , 1996, European journal of pharmacology.
[140] S. Higuchi,et al. Functional polymorphisms in the sigma1 receptor gene associated with alcoholism , 2003, Biological Psychiatry.
[141] M. Itokawa,et al. Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia , 1998, Neuroscience Letters.
[142] V. Ganapathy,et al. Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand. , 2007, Investigative ophthalmology & visual science.
[143] V. Ganapathy,et al. The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate. , 2004, Brain research. Molecular brain research.
[144] C. Montigny,et al. Modification of the N-methyl-D-aspartate response by antidepressant σ receptor ligands , 1993 .
[145] A. Beitz,et al. Activation of the spinal sigma‐1 receptor enhances NMDA‐induced pain via PKC‐ and PKA‐dependent phosphorylation of the NR1 subunit in mice , 2008, British journal of pharmacology.
[146] W. Bowen,et al. The sigma1 (σ1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming , 2004, Psychopharmacology.
[147] K. Pennypacker,et al. σ-1 Receptor Modulation of Acid-Sensing Ion Channel a (ASIC1a) and ASIC1a-Induced Ca2+ Influx in Rat Cortical Neurons , 2008, Journal of Pharmacology and Experimental Therapeutics.
[148] P. Kalivas,et al. Brain circuitry and the reinstatement of cocaine-seeking behavior , 2003, Psychopharmacology.
[149] Teruo Hayashi,et al. Regulating ankyrin dynamics: Roles of sigma-1 receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[150] Teruo Hayashi,et al. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. , 2007, Cell.
[151] G. Ponzio,et al. Inhibition of Tumor Cell Proliferation by σ Ligands Is Associated with K+ Channel Inhibition and p27kip1 Accumulation , 2004, Journal of Pharmacology and Experimental Therapeutics.
[152] M. Huber,et al. Efficacy and Safety of the Sigma Receptor Ligand EMD 57445 (Panamesine) in Patients with Schizophrenia: an Open Clinical Trial , 1999, Pharmacopsychiatry.
[153] J. Ieni,et al. Antiamnesic and Neuroprotective Effects of Donepezil against Learning Impairments Induced in Mice by Exposure to Carbon Monoxide Gas , 2006, Journal of Pharmacology and Experimental Therapeutics.
[154] T. Nabeshima,et al. Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. , 1999, Japanese journal of pharmacology.
[155] G. Duncan,et al. Silencing of sigma-1 receptor induces cell death in human lens cells. , 2006, Experimental cell research.
[156] K. Pennypacker,et al. Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. , 2006, Current neurovascular research.
[157] M. Lerner,et al. Cocaine Up-Regulates Fra-2 and σ-1 Receptor Gene and Protein Expression in Brain Regions Involved in Addiction and Reward , 2005, Journal of Pharmacology and Experimental Therapeutics.
[158] A. Privat,et al. Sigma1 (σ 1) receptor agonists and neurosteroids attenuate β 25–35-amyloid peptide-induced amnesia in mice through a common mechanism , 1998, Neuroscience.
[159] B. Leonard,et al. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor , 1991, Brain Research.
[160] W. Bowen,et al. Differential Effects of σ1 Receptor Blockade on Self-Administration and Conditioned Reinstatement Motivated by Cocaine vs Natural Reward , 2007, Neuropsychopharmacology.
[161] R. Matsumoto,et al. Interactions between 3,4-methylenedioxymethamphetamine and σ1 Receptors , 2006 .
[162] W. Bowen,et al. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. , 1994, European journal of pharmacology.
[163] N. Nishiyama,et al. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice , 2009, Psychopharmacology.
[164] Sufang Yang,et al. Sigma Receptor Agonists Provide Neuroprotection In Vitro by Preserving bcl-2 , 2007, Anesthesia and analgesia.
[165] K. Pennypacker,et al. Sigma-1 Receptor Activation Prevents Intracellular Calcium Dysregulation in Cortical Neurons during in Vitro Ischemia , 2006, Journal of Pharmacology and Experimental Therapeutics.
[166] T. Terao,et al. Polymorphisms of the σ1 receptor gene in schizophrenia: An association study , 2000 .
[167] L. Montoliu,et al. Formalin-induced pain is reduced in sigma(1) receptor knockout mice. , 2005, European journal of pharmacology.
[168] I. Guillemain,et al. Differential involvement of the sigma(1) (sigma(1)) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse. , 2001, British Journal of Pharmacology.
[169] Thomas Farkas,et al. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. , 2005, Cancer research.
[170] R. Matsumoto,et al. Alterations in Fos-Related Antigen 2 and σ1 Receptor Gene and Protein Expression Are Associated with the Development of Cocaine-Induced Behavioral Sensitization: Time Course and Regional Distribution Studies , 2008, Journal of Pharmacology and Experimental Therapeutics.
[171] Teruo Hayashi,et al. When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor , 2009, Science Signaling.
[172] E. London,et al. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. , 1988, Science.
[173] R. Wilke,et al. Membrane‐delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G‐protein nor ATP , 2000, The Journal of physiology.
[174] T. Mavlyutov,et al. Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells , 2007, Journal of molecular signaling.
[175] Teruo Hayashi,et al. Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.
[176] S. Homan,et al. Overexpression of sigma receptors in nonneural human tumors. , 1991, Cancer research.
[177] T. Maurice,et al. Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[178] V. Dawson,et al. Neuroprotective effect of σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production , 2001 .
[179] T. Su,et al. Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity , 2005, Neuroreport.
[180] A. Privat,et al. SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. , 1997, European journal of pharmacology.
[181] G. Debonnel,et al. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus , 2005, Synapse.
[182] G. Pasternak,et al. Enhanced κ-opioid receptor-mediated analgesia by antisense targeting the σ1 receptor , 1997 .
[183] D. V. van Helden,et al. The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells. , 1996, Biochemical and biophysical research communications.
[184] P. Hurn,et al. Sigma 1 Receptor Agonists Act as Neuroprotective Drugs Through Inhibition of Inducible Nitric Oxide Synthase , 2006, Anesthesia and analgesia.
[185] Li Zhu,et al. IL-10 Mediates Sigma1 Receptor-Dependent Suppression of Antitumor Immunity1 , 2003, The Journal of Immunology.
[186] G. Debonnel,et al. The role of sigma receptors in depression. , 2005, Journal of pharmacological sciences.
[187] M. Martina,et al. The sigma‐1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus , 2007, The Journal of physiology.
[188] A. Mensah-Nyagan,et al. Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[189] M. Jackson,et al. The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.
[190] R. Matsumoto,et al. Involvement of sigma (σ) receptors in the acute actions of methamphetamine: Receptor binding and behavioral studies , 2005, Neuropharmacology.
[191] E. Kempner,et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.